Semaglutide shots at $249 a month and tirzepatide at $299 after a $99 first month, with a sublingual tablet for either if you'd rather skip the needle — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't.
Semaglutide from $249/mo · Tirzepatide from $299/mo
- SkinnyRx lists semaglutide at $249 a month, $74 more than Nova MD's $175, about $888 a year over 12 billing periods.
- SkinnyRx lists tirzepatide at $299 a month, $100 more than Nova MD's $199, about $1,200 a year over 12 billing periods.
- Neither SkinnyRx nor Nova MD requires a live video visit to get started.
- SkinnyRx lists an oral option (a pill or under-the-tongue form); Nova MD doesn't.
- SkinnyRx lists a narrower service area; Nova MD doesn't publish a full state list.
- SkinnyRx has received an FDA warning letter of its own; our review covers what it says.
- From the signups I walked: SkinnyRx shows its price before the intake questions and Nova MD shows it after.
- On signup ease (Nap-time-easy signup), SkinnyRx scores 64 and Nova MD scores 78, a 14-point gap in favor of Nova MD.